References
1 Bhatia R, Ryscavage P, Taiwo B. Accelerated aging and human
immunodeficiency virus infection: Emerging challenges of growing older
in the era of successful antiretroviral therapy. J Neurovirol 2012;18 :247-55.
2 Deeks SG. Immune dysfunction, inflammation, and accelerated aging in
patients on antiretroviral therapy. Top HIV Med 2009;17 :118-23.
3 Capeau J. Premature Aging and Premature Age-Related Comorbidities in
HIV-Infected Patients: Facts and Hypotheses. Clin Infect Dis 2011;53 :1127-9.
4 Deeks SG. HIV infection, inflammation, immunosenescence, and aging.
Annu Rev Med 2011; 62 :141-55.
5 Molina-Pinelo S, Vallejo A, Díaz L, Soriano-Sarabia N,
Ferrando-Martínez S, Resino S, Muñoz-Fernández MA, Leal M. Premature
immunosenescence in HIV-infected patients on highly active
antiretroviral therapy with low-level CD4 T cell repopulation. J
Antimicrob Chemother 2009; 64 :579-88.
6 Desai S, Landay A. Early Immune senescence in HIV disease. Curr
HIV/AIDS Rep 2010; 7 :4-10.
7 Bischof J, Gärtner F, Zeiser K et al. Immune cells and
immunosenescence. Folia Biol (Praha) 2019; 65 :53-63.
8 Appay V, Sauce D. Immune activation and inflammation in HIV-1
infection: causes and consequences. J Pathol 2010; 214 :231-41.
9 Kelley CF, Kitchen CMR, Hunt PW. et al. Incomplete peripheral
CD4+ cell count restoration in HIV-infected patients receiving long-term
antiretroviral treatment. Clin Infect Dis 2009; 48 :787-94.
10 Douek DC, Mcfarland RD, Keiser PH. et al. Changes in thymic
function with age and during the treatment of HIV infection. Nature
1998; 396 :690-5.
11 Franzese O, Barbaccia ML, Bonmassar E, Graziani G. Beneficial and
Detrimental Effects of Antiretroviral Therapy on HIV-Associated
Immunosenescence. Chemotherapy (Los Angel) 2018; 63 :64-75.
12 Cohen J, Torres C. HIV-associated cellular senescence: a contributor
to accelerated aging. Ageing Res Rev 2017; 36 :117-24.
13 Eberhard JM, Ahmad F, Hong HS, Bhatnagar N, Keudel P, Schulze Zur
Wiesch J, Schmidt RE, Meyer-Olson D. Partial recovery of senescence and
differentiation disturbances in CD8(+) T cell effector-memory cells in
HIV-1 infection after initiation of ART. Clin Exp Immunol 2016;186 :227-38.
14 Behrens NE, Wertheimer A, Klotz SA, Ahmad N. Reduction in terminally
differentiated T cells in virologically controlled HIV-infected aging
patients on long-term antiretroviral therapy. PLoS One 2018;13 :e0199101-0199101.
15 Ananworanich J, Apornpong T, Kosalaraksa P. et al.Characteristics of lymphocyte subsets in HIV-infected, long-term
non-progressor, and healthy Asian children through 12 years of age. J
Allergy Clin Immunol 2010; 126 :1294-301.e10.
16 Ssewanyana I, Baker CA, Ruel T. et al. The Distribution and
Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.
AIDS Res Hum Retroviruses 2008; 25 :65-71.
17 McLane LM, Banerjee PP, Cosma GL, Makedonas G, Wherry EJ, Orange JS,
Betts MR. Differential localization of T-bet and Eomes in CD8
T-cell memory populations. J Immunol 2013; 190 :3207-15.
18 De MM, Rossi ME, Azzari C, Gelli MG, Galli L, Vierucci A. Different
meaning of CD38 molecule expression on CD4+ and CD8+ cells of children
perinatally infected with human immunodeficiency virus type 1 infection
surviving longer than five years. Pediatr Res 1998; 43 :752-8.
19 Brenchley JM, Karandikar NJ, Betts MR. et al. Expression of
CD57 defines replicative senescence and antigen-induced apoptotic death
of CD8+ T cells. Blood 2003; 101 :2711-20.
20 Cawthon RM. Telomere length measurement by a novel monochrome
multiplex quantitative PCR method. Nucleic Acids Res 2009;37 :e21.
21 Deeks SG, Verdin E, Mccune JM. Immunosenescence and HIV. Curr Opin
Immunol 2012; 24 :501-6.
22 Dion, MarieLise, Poulin. et al. HIV Infection Rapidly Induces
and Maintains a Substantial Suppression of Thymocyte Proliferation.
Immunity 2004; 21 :757-68.
23 Fabre-Mersseman V, Dutrieux J, Louise A. et al. CD4+ recent
thymic emigrants are infected by HIV in vivo, implication for
pathogenesis. AIDS 2011; 25 :1153-62.
24 Lelièvre JD, Melica G, Itti E. et al. Initiation of c-ART in
HIV-1 infected patients is associated with a decrease of the metabolic
activity of the thymus evaluated using FDG-PET/computed tomography. J
Acquir Immune Defic Syndr 2012; 61 :56-63.
25 Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, Herzenberg
LA. CD8 naive T cell counts decrease progressively in HIV-infected
adults. J Clin Invest 1995; 95 :2061-6.
26 Méndez-Lagares G, Díaz L, Correa-Rocha R. et al. Specific
patterns of CD4-associated immunosenescence in vertically HIV-infected
subjects. Clin Microbiol Infect 2013; 19 :558-65.
27 Duffau P, Wittkop L, Lazaro E. et al. Association of
immune-activation and senescence markers with non-AIDS-defining
comorbidities in HIV-suppressed patients. AIDS 2015;29 :2099-108.
28 Resino S, Navarro J, Bellón JM, Gurbindo D, León JA, Muñoz-Fernández
MA. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1
infected children on HAART. Clin Exp Immunol 2010; 125 :266-73.
29 Shay JW, Wright WE. Hallmarks of telomeres in ageing research. J
Pathol 2010; 211 :114-23.
30 Appay V, Sauce D. Assessing immune aging in HIV-infected patients.
Virulence 2017; 8 :529-38.
31 Wolthers KC, Wisman G, Otto SA. et al. T cell telomere length
in HIV-1 infection: No evidence for increased CD4+ T cell turnover.
Science 1996;274 :1543-7.
32 Ketty G, Antoni NJ, Marisa Z. et al. Premature aging and
immune senescence in HIV-infected children. AIDS 2016;30 :1363-73.
33 Tucker V, Jenkins J, Gilmour J, Savoie H, Easterbrook P, Gotch F,
Browning MJ. T-cell telomere length maintained in HIV-infected long-term
survivors. HIV Med 2010; 1 :116-22.
34 Leeansyah E, Cameron PU, Solomon A. et al. Inhibition of
telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide
reverse transcriptase inhibitors: a potential factor contributing to
HIV-associated accelerated aging. J Infect Dis 2013;207 :1157-65.
35 Ballon G, Ometto L, Righetti E, Cattelan AM, Masiero S, Zanchetta M,
Chieco-Bianchi L, De Rossi A. Human immunodeficiency virus type 1
modulates telomerase activity in peripheral blood lymphocytes. J Infect
Dis 2001; 183 :417-24.
36 Wolthers KC, Otto SA, Wisman GB, Fleury S, Reiss P, ten Kate RW, van
der Zee AG, Miedema F. Normal T-cell telomerase activity and
upregulation in human immunodeficiency virus-1 infection. Blood 1999;93 :1011-9.